Note: These presentations are not eligible for CME credits.
Moderator: Gregory W. Randolph, MD, FACS, FACE
Speakers: Marcin Barczyński MD, PhD, FEBS-ES; Rick G. Schneider, MD, PhD, FEBS-ES; Michael C. Singer, MD, FACS, FACE
Join this interactive discussion with world-renowned surgical experts to learn about the latest developments in head and neck surgery solutions to help you give patients the best chance for successful surgery — and help protect quality of life.
Speakers: Dr Lori Wirth, MD Oncologist Massachusetts General Hospital; Dr Brian McIver MD, Oncologist
Topic: TKIs Therapy in RAI-DTC, Educate HCPs on the optimal ‘window’ in which to initiate TKI therapy and the impact of delayed initiation on overall survival.
Title and Agenda TBC
Chair: Laura Fugazzola
Speakers: Lori Wirth and Rossella Elisei
With the continued discovery of new genomic targets in thyroid cancer, keeping up to date with the latest advances in targeted therapy can be challenging. In this interactive symposium and case-based panel discussion, world-renowned experts will discuss recent advances in molecular testing and targeted treatments for advanced thyroid cancer and contextualize how these advances can be translated into clinical practice using real-life cases.
This symposium has been funded by a grant for Independent Medical Education provided by Lilly. The Company has had no input to the content.
There are outstanding opportunities for industry participation. For more details on the available sponsorship and exhibitor options, please contact:
Rebecca Darling, rebecca@bayleygroup.com Call: +1. 519.263.5050 / +1. 519.263.6001 (direct) Toll Free: 1.888.527.3434 (North America only) |
Cass Bayley cass@bayleygroup.com Call: +1. 519.263.5050 / +1. 519.263.6000 (direct) Toll Free: 1.888.527.3434 (North America only) |